PIMCO closed-end funds like PTY, PCN, and PDI currently trade at valuations near the lower end of their long-term ranges, offering appealing yields. These funds maintain leverage below historical averages, allowing flexibility to boost income and support distributions if needed. Although distribution coverage ratios are slightly below 100%, recent ATM offerings help reduce the risk of cuts. The analyst recommends overweight positions in PTY and PCN, with a significant allocation to PDI, due to their yield, valuation, and structural benefits, making them attractive for income-focused investors.
The global AI in Pathology market, valued at $28.75 million in 2025, is projected to grow at a 9.12% CAGR to reach $68.81 million by 2035. Growth is driven by rising demand for digital pathology, AI diagnostics, and improved workflow efficiency throu...
The global AI data center market is rapidly expanding due to the rise of generative AI and advanced cognitive analytics, requiring purpose-built, high-density facilities with advanced cooling and networking technologies. Hyperscalers like Microsoft, ...
SKYRIZI achieved blockbuster sales of $11.7 billion in 2024, growing 51% year-over-year, driven by approvals in psoriasis, psoriatic arthritis, and inflammatory bowel diseases like Crohn's. Its strong clinical efficacy targeting the IL-23 pathway and...
The global photodynamic therapy (PDT) market is forecasted to grow from $749 million in 2023 to $1.53 billion by 2035, at a CAGR of 8.3%. Growth is fueled by PDT's minimally invasive nature and expanding applications in oncology, dermatology, and ant...
The cancer metabolism-based therapeutics market is projected to grow from $3.7 billion in 2026 to $26.3 billion by 2035, with a CAGR of 24.3%. This growth is fueled by advances in precision medicine targeting unique cancer cell metabolic pathways, in...
